High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival.

@article{Poen1996HighdoseTA,
  title={High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival.},
  author={Joseph C. Poen and Richard T Hoppe and Sundya J. Horning},
  journal={International journal of radiation oncology, biology, physics},
  year={1996},
  volume={36 1},
  pages={
          3-12
        }
}
PURPOSE To assess the efficacy and toxicity of involved field (IF) radiotherapy in conjunction with high-dose therapy (HDT) and autologous bone marrow transplantation (ABMT) in relapsed or refractory Hodgkin's disease (HD). METHODS AND MATERIALS Between 1987 and 1994, 100 consecutive patients with relapsed or refractory HD were treated with high-dose carmustine, etoposide, and cyclophosphamide or fractionated total-body irradiation, high-dose etoposide, and cyclophosphamide before ABMT. In… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

  • Advances in hematology
  • 2011
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma.

  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2012
VIEW 2 EXCERPTS
CITES BACKGROUND & METHODS

Similar Papers

Loading similar papers…